Personal information

United States

Activities

Employment (6)

Stanford University: Palo Alto, California, US

2022-01-03 to present | Postdoctoral Scholar (Pediatrics Cardiology)
Employment
Source: Self-asserted source
Mir S Adil

Charlie Norwood VA Medical Center: Augusta, Georgia, US

2017-08-08 to 2021-12-31 | Research Pharmacologist (Clinical and Experimental Therapeutics)
Employment
Source: Self-asserted source
Mir S Adil

Aster Prime Hospital: Hyderabad, Andhra Pradesh, IN

2016-12 to 2017-06 | H.O.D., Clinical Pharmacologist (Clinical Pharmacy and Clinical Trials)
Employment
Source: Self-asserted source
Mir S Adil

Apollo Hospitals: Hyderabad, Telangana, IN

2014-12 to 2016-12 | Clinical Pharmacist (Prescription Audit)
Employment
Source: Self-asserted source
Mir S Adil

Jeevan Scientific Technology Ltd: Hyderabad, Telangana, IN

2014-09 to 2014-12 | Associate Medical Writer (Clinical Research)
Employment
Source: Self-asserted source
Mir S Adil

DesiMD Healthcare Pvt Ltd: Hyderabad, Telangana, IN

2014-07 to 2014-09 | Medical Writer
Employment
Source: Self-asserted source
Mir S Adil

Education and qualifications (2)

University of Georgia: Athens, GA, US

2017-08-08 to 2021-12-31 | PhD (Clinical and Experimental Therapeutics)
Education
Source: Self-asserted source
Mir S Adil

Jawaharlal Nehru Technological University: Hyderabad, Telangana, IN

2008-11-01 to 2014-06-30 | PharmD (Pharmacy)
Education
Source: Self-asserted source
Mir S Adil

Professional activities (21)

Scirea Journal of Clinical Medicine: City, IN

Editorial Board Member
Service
Source: Self-asserted source
Mir S Adil

Pharmaceutical Research: Current Trends: City, IN

Editorial Board Member
Service
Source: Self-asserted source
Mir S Adil

Dove Medical Press Ltd: Auckland, NZ

Consulting Editor (Integrated Pharmacy Research & Practice, Core Evidence)
Service
Source: Self-asserted source
Mir S Adil

Andhra Pradesh Pharmacy Council: Hyderabad, Andhra Pradesh, IN

Registered Pharmacist
Membership
Source: Self-asserted source
Mir S Adil

Acta Scientific: Hyderabad, Telangana, IN

Editorial Board Member
Service
Source: Self-asserted source
Mir S Adil

University of Georgia: Athens, Georgia, US

2022-04 | Received Career Development Certificate for greatly contributing to the career development of graduate students in the Class of 2021
Distinction
Source: Self-asserted source
Mir S Adil

EU Open Screen: Berlin, DE

2021-05 | Best Poster Award + 100€ Prize Reward at European Chemical Biology Symposium
Distinction
Source: Self-asserted source
Mir S Adil

Charlie Norwood VA Medical Center: Augusta, Georgia, US

2021-05 | Certificate of Appreciation + $50 Prize Reward for Drafting VA Research Day 2021 Abstract BookCertificate of Appreciation + $50 prize reward for Drafting VA Research Day 2021 Abstract Book Issued by Charlie Norwood VAMC Research Department
Distinction
Source: Self-asserted source
Mir S Adil

American Association for the Advancement of Science: Washington, DC, US

2020-04-01 to 2021-03-31
Membership
Source: Self-asserted source
Mir S Adil

University of Georgia: Athens, Georgia, US

2021 | Travel Award to attend FASEB Conference 2021
Distinction
Source: Self-asserted source
Mir S Adil

Georgia Science and Engineering Fair: Athens, GA, US

2020-03-23 to 2020-03-27 | Judge for Senior Tier 1 Poster Presentation (Health and Biomedical Sciences)
Invited position
Source: Self-asserted source
Mir S Adil

India Student Hub U.S.A.: Washington, DC, US

2019 to 2020 | Campus Lead
Service
Source: Self-asserted source
Mir S Adil

University of Georgia: Athens, GA, US

2019 | Excellence in Literature Evaluation (Clinical and Experimental Therapeutics)
Distinction
Source: Self-asserted source
Mir S Adil

Charlie Norwood VA Medical Center: Augusta, Georgia, US

2019 | 3rd Position in Poster Presentation
Distinction
Source: Self-asserted source
Mir S Adil

Sultan-ul-Uloom College of Pharmacy: Hyderabad, Telangana, IN

2017 to 2017 | Judge for Poster Presentation (Pharmacy)
Invited position
Source: Self-asserted source
Mir S Adil

Deccan School of Pharmacy: Hyderabad, Telangana, IN

2013-07 to 2014-06 | Junior Editor (Clini-Pharma Insight (College Magazine))
Invited position
Source: Self-asserted source
Mir S Adil

Deccan School of Pharmacy: Hyderabad, Telangana, IN

2014 | Best Research Contribution Award (Pharmacy)
Distinction
Source: Self-asserted source
Mir S Adil

Deccan School of Pharmacy: Hyderabad, Telangana, IN

2014 | Outstanding Student of the Year Award
Distinction
Source: Self-asserted source
Mir S Adil

Deccan School of Pharmacy: Hyderabad, Telangana, IN

2014 | Merit Award
Distinction
Source: Self-asserted source
Mir S Adil

Osmania University: Hyderabad, IN

2013 | 3rd Position in Quiz Competition (Pharmacy)
Distinction
Source: Self-asserted source
Mir S Adil

Royal Society of Chemistry: London, London, GB

2010 | Top 5 (Quiz Held in Hyderabad, India)
Distinction
Source: Self-asserted source
Mir S Adil

Works (24)

Reduced FOXF1 links unrepaired DNA damage to pulmonary arterial hypertension.

Nature communications
2023-11-21 | Journal article
Part of ISSN: 2041-1723
Contributors: Sarasa Isobe; Ramesh V Nair; Helen Y Kang; Lingli Wang; Jan-Renier R Moonen; Tsutomu Shinohara; Aiqin Cao; Shalina Taylor; Shoichiro Otsuki; David P Marciano et al.
Source: check_circle
Stanford University

Elevated Intracranial Pressure in Cryptococcal Meningoencephalitis: Examining Old, New, and Promising Drug Therapies

Pathogens
2022-07-10 | Journal article
Contributors: Abdulaziz H. Alanazi; Mir S. Adil; Xiaorong Lin; Daniel B. Chastain; Andrés F. Henao-Martínez; Carlos Franco-Paredes; Payaningal R. Somanath
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Claudin-17 Deficiency in Mice Results in Kidney Injury Due to Electrolyte Imbalance and Oxidative Stress

Cells
2022-05-29 | Journal article
Contributors: Mir S. Adil; Varun Parvathagiri; Arti Verma; Fang Liu; Madhuri Rudraraju; S. Priya Narayanan; Payaningal R. Somanath
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Regulation of Let-7a-5p and miR-199a-5p Expression by Akt1 Modulates Prostate Cancer Epithelial-to-Mesenchymal Transition via the Transforming Growth Factor-β Pathway

Cancers
2022-03 | Journal article | Author
Contributors: Abdulrahman Alwhaibi; Varun Parvathagiri; Arti Verma; sandeep artham; Mir S Adil; Payaningal R Somanath
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 3)‎

Bioinformatics analyses reveal cell-barrier junction modulations in lung epithelial cells on SARS-CoV-2 infection.

Tissue barriers
2021-11-05 | Journal article
Source: Self-asserted source
Mir S Adil
grade
Preferred source (of 2)‎

Neuroprotective Effects of Fingolimod in a Cellular Model of Optic Neuritis

Cells
2021-10-28 | Journal article
Contributors: Amritha A. Candadai; Fang Liu; Arti Verma; Mir S. Adil; Moaddey Alfarhan; Susan C. Fagan; Payaningal R. Somanath; S. Priya Narayanan
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Targeting Akt-associated microRNAs for cancer therapeutics

Biochemical Pharmacology
2021-07 | Journal article
Contributors: Mir S. Adil; Daulat Khulood; Payaningal R. Somanath
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Akt-independent effects of triciribine on ACE2 expression in human lung epithelial cells: Potential benefits in restricting SARS-CoV2 infection.

Journal of cellular physiology
2021-02-24 | Journal article
Source: Self-asserted source
Mir S Adil
grade
Preferred source (of 2)‎

Cisatracurium attenuates LPS-induced modulation of MMP3 and junctional protein expression in human microvascular endothelial cells.

Bioscience trends
2021-02-23 | Journal article
Source: Self-asserted source
Mir S Adil
grade
Preferred source (of 2)‎

Endothelial Permeability Assays In Vitro

Methods in Molecular Biology
2020 | Book chapter
Part of ISSN: 1064-3745
Part of ISSN: 1940-6029
Source: Self-asserted source
Mir S Adil
grade
Preferred source (of 2)‎

Vascular Permeability Assays In Vivo

Methods in Molecular Biology
2020 | Book chapter
Part of ISSN: 1064-3745
Part of ISSN: 1940-6029
Source: Self-asserted source
Mir S Adil
grade
Preferred source (of 2)‎

Differential regulation of TGFβ type-I receptor expressions in TGFβ1-induced myofibroblast differentiation

Canadian Journal of Physiology and Pharmacology
2020-12 | Journal article
Part of ISSN: 0008-4212
Part of ISSN: 1205-7541
Source: Self-asserted source
Mir S Adil
grade
Preferred source (of 2)‎

Distinct effects of pharmacological inhibition of stromelysin1 on endothelial‐to‐mesenchymal transition and myofibroblast differentiation

Journal of Cellular Physiology
2020-12-15 | Journal article
Part of ISSN: 0021-9541
Part of ISSN: 1097-4652
Source: Self-asserted source
Mir S Adil
grade
Preferred source (of 2)‎

Cell-cell junctions: structure and regulation in physiology and pathology

Tissue Barriers
2020-12-10 | Journal article
Part of ISSN: 2168-8370
Source: Self-asserted source
Mir S Adil
grade
Preferred source (of 2)‎

Is amiloride a promising cardiovascular medication to persist in the COVID-19 crisis?

Drug discoveries & therapeutics
2020-10-29 | Journal article
Source: Self-asserted source
Mir S Adil
grade
Preferred source (of 2)‎

PAK1 inhibitor IPA-3 mitigates metastatic prostate cancer-induced bone remodeling

Biochemical Pharmacology
2020-07 | Journal article
Part of ISSN: 0006-2952
Source: Self-asserted source
Mir S Adil
grade
Preferred source (of 2)‎

PRIME study: Prescription review to impede medication errors

International Journal of Risk & Safety in Medicine
2020-05-19 | Journal article
Source: Self-asserted source
Mir S Adil
grade
Preferred source (of 2)‎

Delayed Akt suppression in the lipopolysaccharide-induced acute lung injury promotes resolution that is associated with enhanced effector regulatory T cells

American Journal of Physiology-Lung Cellular and Molecular Physiology
2020-04-01 | Journal article
Part of ISSN: 1040-0605
Part of ISSN: 1522-1504
Source: Self-asserted source
Mir S Adil
grade
Preferred source (of 2)‎

Convalescent plasma appears efficacious and safe in COVID-19

Therapeutic Advances in Infectious Disease
2020-01 | Journal article
Contributors: Daulat Khulood; Mir Shoebulla Adil; Ruqiya Sultana; Nimra
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Nodal pathway activation due to Akt1 suppression is a molecular switch for prostate cancer cell epithelial-to-mesenchymal transition and metastasis

Biochemical Pharmacology
2019-10 | Journal article
Part of ISSN: 0006-2952
Source: Self-asserted source
Mir S Adil
grade
Preferred source (of 2)‎

The unconventional role of Akt1 in the advanced cancers and in diabetes-promoted carcinogenesis

Pharmacological Research
2019-07 | Journal article
Part of ISSN: 1043-6618
Source: Self-asserted source
Mir S Adil
grade
Preferred source (of 2)‎

Causality assessment of adverse drug reaction in Pulmonology Department of a Tertiary Care Hospital

Journal of Basic and Clinical Pharmacy
2015 | Journal article
Part of ISSN: 0976-0105
Source: Self-asserted source
Mir S Adil
grade
Preferred source (of 2)‎

EMPADE Study: Evaluation of Medical Prescriptions and Adverse Drug Events in COPD Patients Admitted to Intensive Care Unit

JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
2015 | Journal article
Part of ISSN: 2249-782X
Source: Self-asserted source
Mir S Adil
grade
Preferred source (of 2)‎

ASSESSMENT OF PARENTAL UNDERSTANDING OF PAEDIATRIC MEDICAL PRESCRIPTIONS

INTERNATIONAL JOURNAL OF MEDICAL RESEARCH & HEALTH SCIENCES
2014-01-01 | Journal article
WOSUID:

WOS:000215297100007

Part of ISSN: 2319-5886
Contributors: Anjum, Sadiqua; Mohiuddin, MohdNasir; Reddy, Narayan U.; Rao, Narsing J.; Afreen, Sana; Adil, Mir S.; Javeedullah, M.
Source: check_circle
Stanford University

Peer review (3 reviews for 1 publication/grant)

Review activity for PloS one. (3)